#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5106033	Binding	Inhibition of xanthine oxidase (unknown origin) at 10 uM relative to control	Homo sapiens	21	ALA5104148	single protein format	Scientific Literature
2.	ALA5106034	Toxicity	Cytotoxicity against human L02 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay	Homo sapiens	21	ALA5104148	cell-based format	Scientific Literature
3.	ALA5106035	Functional	Anti-hyperuricemic activity against hypoxanthine and oteracil potassium induced hyperuricemia in Kunming mouse model assessed as uric acid level at 5 mg/kg, IG administered daily (Rvb = 631.6 +/- 103.1 uM)	Mus musculus	3	ALA5104148	organism-based format	Scientific Literature
4.	ALA5106036	Functional	Anti-hyperuricemic activity against hypoxanthine and oteracil potassium induced hyperuricemia in Kunming mouse model assessed as alanine aminotransferase level at 5 mg/kg, IG administered daily (Rvb = 28.05 +/- 8.478 U/L)	Mus musculus	3	ALA5104148	organism-based format	Scientific Literature
5.	ALA5106037	Functional	Anti-hyperuricemic activity against hypoxanthine and oteracil potassium induced hyperuricemia in Kunming mouse model assessed as total bilirubin level at 5 mg/kg, IG administered daily (Rvb = 12.05 +/- 4.92 uM)	Mus musculus	3	ALA5104148	organism-based format	Scientific Literature
6.	ALA5106038	Functional	Anti-hyperuricemic activity against hypoxanthine and oteracil potassium induced hyperuricemia in Kunming mouse model assessed as blood urea nitrogen level at 5 mg/kg, IG administered daily (Rvb = 53.09 +/- 1.937 mg/dl)	Mus musculus	3	ALA5104148	organism-based format	Scientific Literature
7.	ALA5106039	Functional	Anti-hyperuricemic activity against hypoxanthine and oteracil potassium induced hyperuricemia in Kunming mouse model assessed as creatinine level at 5 mg/kg, IG administered daily (Rvb = 59.12 +/- 7.198 uM)	Mus musculus	3	ALA5104148	organism-based format	Scientific Literature
8.	ALA5106040	ADME	Elimination half life in rat at 3 mg/kg, po measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
9.	ALA5106041	ADME	Tmax in rat at 3 mg/kg, po measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
10.	ALA5106042	ADME	Cmax in rat at 3 mg/kg, po measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
11.	ALA5106043	ADME	AUC(0 to t) in rat at 3 mg/kg, po measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
12.	ALA5106044	ADME	AUC(0 to infinity) in rat at 3 mg/kg, po measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
13.	ALA5106045	ADME	Elimination half life in rat at 1 mg/kg, iv measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
14.	ALA5106046	ADME	Tmax in rat at 1 mg/kg, iv measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
15.	ALA5106047	ADME	Cmax in rat at 1 mg/kg, iv measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
16.	ALA5106048	ADME	AUC(0 to t) in rat at 1 mg/kg, iv measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
17.	ALA5106049	ADME	AUC(0 to infinity) in rat at 1 mg/kg, iv measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
18.	ALA5106050	ADME	Clearance in rat at 1 mg/kg, iv measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
19.	ALA5106051	ADME	Volume of distribution in rat at 1 mg/kg, iv measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature
20.	ALA5106052	ADME	Oral bioavailability in rat at 3 mg/kg measured after 24 hrs	Rattus norvegicus	1	ALA5104148	organism-based format	Scientific Literature